ORCHID PHARMA
|
ORCHID PHARMA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 19.65 | 18.17 | 11.35 | -0.48 | -28.55 |
| CEPS(Rs) | 25.69 | 25.30 | 26.96 | 7.38 | 3.35 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 249.86 | 230.58 | 168.72 | 158.61 | 159.96 |
| Tax Rate(%) | -0.20 | -3.39 | - | - | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.00 | 13.52 | 12.66 | 9.75 | 11.26 |
| EBIT Margin(%) | 11.99 | 13.26 | 13.24 | -4.19 | -9.56 |
| Pre Tax Margin(%) | 10.37 | 11.22 | 8.30 | -10.17 | -21.16 |
| PAT Margin (%) | 10.39 | 11.60 | 8.30 | -10.17 | -21.16 |
| Cash Profit Margin (%) | 14.13 | 15.66 | 16.52 | 5.38 | 3.04 |
| Performance Ratios | |||||
| ROA(%) | 5.91 | 6.84 | 4.73 | -4.85 | -7.06 |
| ROE(%) | 7.86 | 10.23 | 8.27 | -8.75 | -13.43 |
| ROCE(%) | 8.05 | 9.35 | 9.11 | -2.32 | -3.53 |
| Asset Turnover(x) | 0.57 | 0.59 | 0.57 | 0.48 | 0.33 |
| Sales/Fixed Asset(x) | 0.70 | 0.65 | 0.56 | 0.48 | 0.37 |
| Working Capital/Sales(x) | 1.77 | 1.54 | 5.16 | 3.90 | 1.57 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.44 | 1.54 | 1.80 | 2.10 | 2.69 |
| Receivable days | 86.58 | 91.49 | 105.72 | 99.89 | 82.59 |
| Inventory Days | 116.91 | 109.80 | 110.01 | 106.18 | 119.45 |
| Payable days | 151.46 | 152.17 | 162.30 | 161.59 | 168.95 |
| Valuation Parameters | |||||
| PER(x) | 39.54 | 57.52 | 33.87 | - | - |
| PCE(x) | 30.24 | 41.32 | 14.26 | 38.52 | 736.19 |
| Price/Book(x) | 3.11 | 4.53 | 2.28 | 1.79 | 15.41 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 4.27 | 6.31 | 2.81 | 2.54 | 23.32 |
| EV/Core EBITDA(x) | 27.13 | 36.42 | 18.03 | 22.34 | 159.31 |
| EV/EBIT(x) | 35.61 | 47.56 | 21.21 | -60.59 | -243.82 |
| EV/CE(x) | 2.73 | 3.96 | 1.83 | 1.55 | 9.49 |
| M Cap / Sales | 4.27 | 6.47 | 2.36 | 2.07 | 22.36 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 12.52 | 23.05 | 19.00 | 24.33 | -6.97 |
| Core EBITDA Growth(%) | 2.20 | 36.82 | 63.14 | -3.48 | 20.95 |
| EBIT Growth(%) | 1.67 | 23.29 | 476.02 | 45.54 | 32.18 |
| PAT Growth(%) | 0.73 | 72.07 | 197.10 | 40.26 | -36.67 |
| EPS Growth(%) | 8.13 | 60.13 | 2,474.06 | 98.33 | 11.09 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.14 | 0.12 | 0.48 | 0.41 | 0.69 |
| Current Ratio(x) | 2.83 | 3.04 | 1.35 | 1.60 | 3.02 |
| Quick Ratio(x) | 1.68 | 2.03 | 0.73 | 0.88 | 1.94 |
| Interest Cover(x) | 7.40 | 6.49 | 2.68 | -0.70 | -0.82 |
| Total Debt/Mcap(x) | 0.04 | 0.03 | 0.21 | 0.23 | 0.04 |
Compare Financial Ratios of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹3,699.1 Cr | -7% | -12.7% | -59.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -7% |
-12.7% |
-59.7% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses
